Menu

NPPA cut cancer drug prices from Nov 9. Did it actually help people, or was it all make-believe?

#india#redditindia#dose#first#drugs
Reading 0:00
15s threshold

My mom has stage 4 metastatic breast cancer and is on Zydus's Sigrima (a pertuzumab biosimilar). The hospital's package is: we pay ₹78,000 up front for the first dose, the next dose is free, and Vivitra (trastuzumab) comes free with every dose.

I looked through NPPA's revised MRP list to see if anything would help her.

None of the immunotherapy drugs show any significant change. Keytruda is still ₹2,16,500, and Opdyta, Tecentriq and Imfinzi are unchanged too.

The drugs that did drop, like palbociclib (₹40,421 → ₹2,720) and thiotepa (₹80,072 → ₹7,150), only fell because the old MRPs were inflated in the first place.

So is this a real saving for patients like my mom, or just fixing a number that was never real?

submitted by /u/levitating-being
[link] [comments]